On May 22, a research team composed of multi-disciplinary experts which included Gong Ke, chairman of the World Federation of Engineering Organizations visited Novozymes Biotechnology, a company located in the Tianjin Development Zone.

Novozymes is a global biotechnology company headquartered in Denmark. It is included as a Fortune 500 company and it is engaged in research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients.

Soren Carsen, Vice-president of Novozymes welcomed the research time on behalf of the company. Gong Ke and his party visited the workshop and the logistics warehouse to learn more about the actual needs of the company.

A brief meeting was prepared for this occasion. Carlsen introduced the history, the business philosophy, the operation status, the actual production of the company and the prospective for the future, which will include an upgrade plan and the use of artificial intelligence. Both parties expressed the value of this opportunity for further cooperation.

Professor Liu Jingtai, Associate Professor Qing Yanding and Associate Professor Sun Ning, introduced the research work done by the Institute of Robotics and Informatic Automation of Nankai University on the application of remote-control robots and anti-sway system. Li Weizun, senior engineer of the National Local Joint Engineering Research Center, introduced the methods applied by their R&D team on the treatment of solid waste.

Pang Ruizhi, Professor at the College of Economic and Social Development, made suggestions from the perspective of the development of the biopharmaceutical industry. Both parties expressed the value of this opportunity for further cooperation. 

Gong Ke praised Novozymes' contribution to global sustainable development. He also introduced China ’s new generation of artificial intelligence. As a cross-cultural think tank platform connecting government, universities, research institutes, and intelligent enterprises, Gong is willing to provide intelligence for enterprises as Novozymes.